P. Di Gianni et al., Inhibition of metastases by a serum factor associated to concomitant resistance induced by unrelated murine tumors, ONCOL REP, 6(5), 1999, pp. 1073-1084
Murine lung metatases growing undisturbed by the primary tumor were signifi
cantly inhibited by the concomitant resistance induced by a secondary subcu
taneous implant of two unrelated tumors. Such inhibition was T-independent
since it was also observed in nude mice; its full expression was dependent
on the presence of the secondary tumor implant and it was exerted on both m
acroscopic and microscopic established metastases and not on the process of
tumor cell dissemination from the primary tumor. Direct and indirect mecha
nisms seemed to be involved, the former affecting the metastatic cells per
se by causing a decrease in proliferation and an increase in apoptosis whil
e the latter affected neovascularization. These antitumor and antiangiogeni
c effects could be attributed to a serum factor induced by the unrelated tu
mors generating concomitant resistance. This factor proved to be heat, acid
and alkaline resistant and dialysable; it was recovered in an HPLC column
with maximum absorption at 215 and 266 nm; it was anionic at neutral pH, ex
hibiting free carboxil groups and one or more molecules of tyrosine, with a
molecular weight between 870 and 1300 Dalton. Intravenous administration o
f this factor significantly inhibited lung metastases, decreasing mitosis a
nd increasing apoptosis similar to that observed in the presence of the unr
elated tumors.